Oxypertine

This classification denotes a dopamine antagonist with the molecular formula C23H29N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5JGL4G25R7, chemically known as 5,6-dimethoxy-2-methyl-3-(2-(4-phenyl-1-piperazinyl)ethyl)indole but generally known as oxypertine, which bears US NIH Compound Identifier 4640. European Medicines Agency schedules Oxypertine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09571MIG. The term OXYPERTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules oxypertine in its Anatomical Therapeutic Chemical (ATC) Classification. OXYPERTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxypertine under HS 29335995 and SITC 51576. As of Q4 2014, OXYPERTINE remains the US FDA Preferred Term for this commodity. Oxypertine bears US NLM identifiers UMLS ID C0030077 and NCI Concept Code C87711. SMILES: O(c1cc2c(CCN3CCN(CC3)c3ccccc3)c([nH]c2cc1OC)C)C.